このエントリーをはてなブックマークに追加
ID 63766
フルテキストURL
著者
Fujimori, Takumi Microbiology Division, Clinical Laboratory, Okayama University Hospital
Hagiya, Hideharu Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences ORCID Kaken ID researchmap
Iio, Koji Microbiology Division, Clinical Laboratory, Okayama University Hospital
Higashionna, Tsukasa Department of Pharmacy, Okayama University Hospital
Kakehi, Ayaka Microbiology Division, Clinical Laboratory, Okayama University Hospital
Okura, Mami Microbiology Division, Clinical Laboratory, Okayama University Hospital
Minabe, Hiroshi Microbiology Division, Clinical Laboratory, Okayama University Hospital
Yokoyama, Yukika Microbiology Division, Clinical Laboratory, Okayama University Hospital
Otsuka, Fumio Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences ORCID Kaken ID publons researchmap
Higashikage, Akihito Microbiology Division, Clinical Laboratory, Okayama University Hospital
抄録
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of nosocomial and community infections, and vancomycin (VCM) is widely recommended as a first-line therapeutic drug. Minimum inhibitory concentrations (MICs) of VCM <2 mu g/mL are defined as susceptible, but increases in these levels, known as "VCM MIC creep" have been reported. The aim of this study was to investigate VCM MIC creep during the promotion of a national antimicrobial stewardship campaign.
Methods: We collected data from 2013 to 2020 on S. aureus isolated at the clinical microbiology laboratory at Okayama University Hospital, Japan. We calculated the annual proportions of MRSA isolation rates by MIC levels for nosocomial and community samples and estimated annual percentage changes in the antimicrobial use density of the VCM.
Results: Of the 1,716 MRSA isolates, no strains showed intermediate or resistant ranges of VCM MIC levels. By 2020, the proportion of MRSA with an MIC of <0.5 mu g/mL decreased to 35.4%, while that with an MIC of 1 mu g/ mL increased to 64.1% over time. The annual percentage changes of the VCM antimicrobial use density significantly increased without any trend change point (average 8.1%, p = 0.035). There was no clear correlation between the VCM AUD and annual proportion of nosocomial MRSA with MIC 1 mu g/mL (correlation coefficient 0.48; p value = 0.24).
Conclusion: We demonstrated a deteriorating situation of VCM MIC creep among MRSA strains isolated at our university hospital during the national antimicrobial stewardship campaign.
キーワード
Antimicrobial resistance
Methicillin-resistant Staphylococcus aureus
Vancomycin
Minimum inhibitory concentration
Creep
Antimicrobial resistance
Methicillin-resistant Staphylococcus aureus
Vancomycin
Minimum inhibitory concentration
Creep
備考
© 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. This manuscript version is made available under the CC-BY-NC-ND 4.0 License. http://creativecommons.org/licenses/by-nc-nd/4.0/. This is the accepted manuscript version. The formal published version is available at [https://doi.org/10.1016/j.jiac.2022.03.017] .
発行日
2022-07
出版物タイトル
Journal of Infection and Chemotherapy
28巻
7号
出版者
Elsevier BV
開始ページ
918
終了ページ
922
ISSN
1341-321X
NCID
AA11057978
資料タイプ
学術雑誌論文
言語
英語
OAI-PMH Set
岡山大学
著作権者
© 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases.
論文のバージョン
author
PubMed ID
DOI
Web of Science KeyUT
関連URL
isVersionOf https://doi.org/10.1016/j.jiac.2022.03.017
ライセンス
http://creativecommons.org/licenses/by-nc-nd/4.0/